Triple

T5934372
Position Surface form Disambiguated ID Type / Status
Subject Eurofins Scientific E132007 entity
Predicate hasSubsidiary P254 FINISHED
Object Eurofins Genomics
Eurofins Genomics is a global provider of genomic services and products, including DNA sequencing, oligonucleotide synthesis, and related molecular biology solutions for research, diagnostics, and industry.
 E132007 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Eurofins Genomics | Statement: [Eurofins Scientific, hasSubsidiary, Eurofins Genomics]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: Eurofins Genomics
Context triple: [Eurofins Scientific, hasSubsidiary, Eurofins Genomics]
  • A. Eurofins Scientific
    Eurofins Scientific is a global leader in bioanalytical testing services, specializing in food, environmental, pharmaceutical, and clinical laboratory analysis.
  • B. Horizon Discovery
    Horizon Discovery is a biotechnology company specializing in gene editing and cell-based research tools used for drug discovery and development.
  • C. Thermo Fisher Scientific
    Thermo Fisher Scientific is a leading American biotechnology and laboratory equipment company that provides scientific instruments, reagents, and services to research, healthcare, and industrial customers worldwide.
  • D. New England Biolabs
    New England Biolabs is a biotechnology company renowned for producing molecular biology reagents, particularly restriction enzymes and DNA-modifying tools used in research laboratories worldwide.
  • E. Lonza
    Lonza is a global Swiss-based life sciences company specializing in pharmaceutical, biotech, and nutrition products and services, particularly in contract development and manufacturing.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Eurofins Genomics
Triple: [Eurofins Scientific, hasSubsidiary, Eurofins Genomics]
Generated description
Eurofins Genomics is a global provider of genomic services and products, including DNA sequencing, oligonucleotide synthesis, and related molecular biology solutions for research, diagnostics, and industry.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07 
Target entity: Eurofins Genomics
Target entity description: Eurofins Genomics is a global provider of genomic services and products, including DNA sequencing, oligonucleotide synthesis, and related molecular biology solutions for research, diagnostics, and industry.
  • A. Eurofins Scientific chosen
    Eurofins Scientific is a global leader in bioanalytical testing services, specializing in food, environmental, pharmaceutical, and clinical laboratory analysis.
  • B. Horizon Discovery
    Horizon Discovery is a biotechnology company specializing in gene editing and cell-based research tools used for drug discovery and development.
  • C. Thermo Fisher Scientific
    Thermo Fisher Scientific is a leading American biotechnology and laboratory equipment company that provides scientific instruments, reagents, and services to research, healthcare, and industrial customers worldwide.
  • D. New England Biolabs
    New England Biolabs is a biotechnology company renowned for producing molecular biology reagents, particularly restriction enzymes and DNA-modifying tools used in research laboratories worldwide.
  • E. Lonza
    Lonza is a global Swiss-based life sciences company specializing in pharmaceutical, biotech, and nutrition products and services, particularly in contract development and manufacturing.
  • F. None of above.

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69c0085c55dc8190aa90e242c956e2fa completed March 22, 2026, 3:18 p.m.
NER Named-entity recognition batch_69c038a0c4e481908170d615330edb1a completed March 22, 2026, 6:44 p.m.
NED1 Entity disambiguation (via context triple) batch_69c0c069e450819096b268637ffcd219 completed March 23, 2026, 4:24 a.m.
NEDg Description generation batch_69c0c46fabf081908484ba066c25187b completed March 23, 2026, 4:41 a.m.
NED2 Entity disambiguation (via description) batch_69c0c4f21528819093a36c07e2637446 completed March 23, 2026, 4:43 a.m.
Created at: March 22, 2026, 4 p.m.